Pharmaceuticals - Community Register

  

Community register of veterinary medicinal products


AUTHORISED  

Product information

Invented name: Purevax RCP   
Auth. number : EU/2/04/052
INN : Not available
ATC: Anatomical main group: QI - Immunologicals
Therapeutic subgroup: QI06 - Immunologicals for felidae
Pharmacological subgroup: QI06A - Cat
Chemical subgroup: QI06AX - Other immunologicals
Chemical substance: QI06AX - Other immunologicals
(See WHO ATCvet Index)
Indication: Vaccine against feline viral rhinotracheitis, feline calicivirosis and feline panleucopenia.
Marketing Authorisation Holder: Merial
29 avenue Tony Garnier, F-69007 Lyon, France

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/02/2005 Centralised - Authorisation EMEA/V/C/90 (2005)475 of 23/02/2005
18/07/2005 Centralised - Variation EMEA/V/C/90/II/1
29/01/2008 Centralised - Variation EMEA/V/C/90/II/2, 3, 4 (2008)393 of 25/01/2008
22/09/2008 Centralised - Variation EMEA/V/C/90/II/5
19/02/2009 Centralised - Variation EMEA/V/C/90/II/6 (2009)1183 of 17/02/2009
24/04/2009 Corrigendum (2009)3108 corr of 21/04/2009
27/01/2010 Centralised - Renewal EMEA/V/C/90/R/7 (2010)532 of 25/01/2010
29/01/2013 Centralised - Variation EMEA/V/C/90/WS/325/G (2013)495 of 24/01/2013
06/05/2014 Centralised - Variation EMEA/V/C/90/IG/430